Plunge in Antiviral Scripts for Hep C Points to Unmet Treatment Needs

Plunge in Antiviral Scripts for Hep C Points to Unmet Treatment Needs

(MedPage Today) -- Hailed as breakthrough treatments at their 2013 debut, the number of direct-acting antiviral (DAA) prescriptions to treat hepatitis C virus (HCV) infections has plummeted by nearly two-thirds in the last decade, according to...

Dramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated

Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment within a year of diagnosis. A new study by investigators from Mass General Brigham and University of Virginia School of Medicine has analyzed a large national prescription database to estimate hepatitis C treatment courses over time and trends by patient and prescriber characteristics f…